Participants will:
• Learn up-to-date information on the current incidence of oral cancer and at-risk populations
• Review the latest research on screening in the general practice dental office
• Become familiar with the latest techniques in oral screening, both aided and unaided
• Receive assistance in communicating the need for universal oral cancer screening
• Be provided guidance moving potential cancer patients up the chain of diagnosis and treatment
Course Description: (Click for Show/Hide)
WNL means within normal limits but are we sure? Oral cancer is one of the most treatable of the major cancers when discovered and treated early. Yet oral cancer (6th most common cancer in the US) is the only major cancer whose incidence is rising when most other cancers are declining. Dental professionals are uniquely positioned to screen patients and detect oral cancer in its early, treatable stage. This course provides a review of the topic and practical recommendations for screening patients in the general practice setting.
Credits: 2.0
Price: 70.00
RX for Insurance Blues: What the Clinical Team Needs to Know and Do
We are moving into the threshold of a golden age of molecular diagnosis and biotech-therapy. Sound like your practice? Maybe not yet, but very soon there will be no choice. You or your practice might not be embracing this brave new world but the insurance industry will take us there whether we want to go or not. Without the connection to current research, practitioners can feel helpless, hopeless and a victim to changes made by others. The alliance between evidence-based (EB) decision making and the insurance industry is already being established. Clinicians need to understand this changing arena to prepare for the future and step up to do their part to optimize patient benefits.
Course Description: (Click for Show/Hide)
We are moving into the threshold of a golden age of molecular diagnosis and biotech-therapy. Sound like your practice? Maybe not yet, but very soon there will be no choice. You or your practice might not be embracing this brave new world but the insurance industry will take us there whether we want to go or not. Without the connection to current research, practitioners can feel helpless, hopeless and a victim to changes made by others. The alliance between evidence-based (EB) decision making and the insurance industry is already being established. Clinicians need to understand this changing arena to prepare for the future and step up to do their part to optimize patient benefits.